Hematology-Oncology
Park, Joon Oh
95 AppointmentProfessor Division of Hematology/Oncology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine
Speciality Interests
Schedule
05 | MON 13 |
TUE 14 |
WEN 15 |
THU 16 |
FRI 17 |
---|---|---|---|---|---|
AM | available | available | |||
PM | available |
Medical School
1996~2001 Ph.D. in Medicine Yonsei University Graduate School of Medical Science, Seoul, Korea 1993~1995 Master in Medicine Yonsei University Graduate School of Medical Science, Seoul, Korea 1985~1991 MD Yonsei University College of Medicine, Seoul, Korea
Specialty Training
Fellowship | 2001~2002 Clinical Fellowship Samsung Medical Center, Sungkyunkwan University School of Medicine 1999~2001 Clinical & Research Fellowship Yonsei Cancer Center, Yonsei Univ. Medical College |
|
---|---|---|
Residency | 1992~1996 Yonsei Severance Hospital, Yonsei Univ. Medical College, Seoul, Korea | |
Internship | 1991~1992 Yonsei Severance Hospital, Yonsei Univ. Medical College, Seoul, Korea |
Other Education
2019~Present Director Director, Precision Medicine Research Center, Samsung Research Institute for Future Medicine, Seoul, Korea
2015~2021 Director Center for Rare Cancers, Samsung Comprehensive Cancer Center, Seoul, Korea
2013~Present Professor Div. of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2007~2013 Associate Professor Div. of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2006~2008 Postdoc. Fellowhsip Dana-Farber Cancer Inst. /Harvard Medical School, Boston, MA
2003~2007 Assistant Professor Div. of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2002~2003 Clinical Assistant Professor Div. of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Participation in Academic Societies
and Research
2022~Present Active member European Society of Medical Oncology (ESMO)
1999~Present Active member American Society of Clinical Oncology (ASCO)
2002~Present Active member American Association of Cancer Research (AACR)
2005~Present Active member Korean Society of Medical Oncology (KSMO)
2001~Present Active member Korean Cancer Study Group (KCSG)
1995~Present Active member Korean Cancer Association
1992~Present Active member Korean Association of Internal Medicine
Thesis
J HEPATO-BIL-PAN SCI 2021 10.1002/jhbp.986
Multi-biomarker panel prediction model for diagnosis of pancreatic cancer
J CLIN ONCOL 2021 10.1200/JCO.20.02232
Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)
ESMO OPEN 2021 10.1016/j.esmoop.2021.100049
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)
CANCERS 2021 10.3390/cancers13071647
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
ANN SURG TREAT RES 2021 10.4174/astr.2021.100.3.144
Diagnostic model for pancreatic cancer using a multi-biomarker panel